A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease

OBJECTIVES: To examine the effectiveness of Janus-kinase inhibitors (JAKis) or abatacept (ABA) in patients with rheumatoid arthritis-interstitial lung disease (RA-ILD). METHODS: Patients with RA-ILD receiving JAKis or ABA were retrospectively evaluated at baseline and after 18 months of treatment. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Tardella, Marika, Di Carlo, Marco, Carotti, Marina, Ceccarelli, Luca, Giovagnoni, Andrea, Salaffi, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135879/
https://www.ncbi.nlm.nih.gov/pubmed/35462572
http://dx.doi.org/10.1007/s10787-022-00936-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135879/
https://www.ncbi.nlm.nih.gov/pubmed/35462572
http://dx.doi.org/10.1007/s10787-022-00936-w

Ejemplares similares